Authors:
NANGIAMAKKER P
SARVIS R
VISSCHER DW
BAILEYPENROD J
RAZ A
SARKAR FH
Citation: P. Nangiamakker et al., GALECTIN-3 AND L1 RETROTRANSPOSONS IN HUMAN BREAST CARCINOMAS, Breast cancer research and treatment, 49(2), 1998, pp. 171-183
Authors:
BRESALIER RS
MAZUREK N
STERNBERG LR
BYRD JC
YUNKER CK
NANGIAMAKKER P
RAZ A
Citation: Rs. Bresalier et al., METASTASIS OF HUMAN COLON-CANCER IS ALTERED BY MODIFYING EXPRESSION OF THE BETA-GALACTOSIDE-BINDING PROTEIN GALECTIN-3, Gastroenterology, 115(2), 1998, pp. 287-296
Authors:
BRESALIER RS
MAZUREK N
STERNBERG L
YUNKER C
BYRD JC
DANIEL S
NANGIAMAKKER P
RAZ A
Citation: Rs. Bresalier et al., MODIFYING EXPRESSION OF THE BETA-GALACTOSIDE-BINDING PROTEIN GALECTIN-3 SIGNIFICANTLY ALTERS THE METASTATIC ABILITY OF HUMAN COLON-CANCER CELLS, Gastroenterology, 114(4), 1998, pp. 2331-2331
Authors:
SHEKHAR MPV
NANGIAMAKKER P
WOLMAN SR
TAIT L
HEPPNER GH
VISSCHER DW
Citation: Mpv. Shekhar et al., DIRECT ACTION OF ESTROGEN ON SEQUENCE OF PROGRESSION OF HUMAN PRENEOPLASTIC BREAST DISEASE, The American journal of pathology, 152(5), 1998, pp. 1129-1132
Authors:
AKAHANI S
NANGIAMAKKER P
INOHARA H
KIM HRC
RAZ A
Citation: S. Akahani et al., GALECTIN-3 - A NOVEL ANTIAPOPTOTIC MOLECULE WITH A FUNCTIONAL BH1 (NWGR) DOMAIN OF BCL-2 FAMILY, Cancer research, 57(23), 1997, pp. 5272-5276
Authors:
NANGIAMAKKER P
THOMPSON E
HOGAN C
OCHIENG J
RAZ A
Citation: P. Nangiamakker et al., INDUCTION OF TUMORIGENICITY BY GALECTIN-3 IN A NONTUMORIGENIC HUMAN BREAST-CARCINOMA CELL-LINE, International journal of oncology, 7(5), 1995, pp. 1079-1087
Authors:
OCHIENG J
FRIDMAN R
NANGIAMAKKER P
KLEINER DE
LIOTTA LA
STETLERSTEVENSON WG
RAZ A
Citation: J. Ochieng et al., GALECTIN-3 IS A NOVEL SUBSTRATE FOR HUMAN MATRIX METALLOPROTEINASE-2 AND METALLOPROTEINASE-9, Biochemistry, 33(47), 1994, pp. 14109-14114
Authors:
NANGIAMAKKER P
OCHIENG J
CHRISTMAN JK
RAZ A
Citation: P. Nangiamakker et al., REGULATION OF THE EXPRESSION OF GALACTOSIDE-BINDING LECTIN DURING HUMAN MONOCYTIC DIFFERENTIATION, Cancer research, 53(20), 1993, pp. 5033-5037